Schear Investment Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.61M Buy
7,178
+167
+2% +$171K 2.88% 7
2026
Q1
$6.45M Sell
7,011
-16
-0.2% -$16.2K 2.84% 10
2025
Q4
$7.55M Sell
7,027
-62
-0.9% -$59.3K 3.25% 9
2025
Q3
$5.41M Buy
7,089
+23
+0.3% +$17.1K 2.41% 11
2025
Q2
$5.51M Sell
7,066
-251
-3% -$195K 2.73% 11
2025
Q1
$6.04M Sell
7,317
-1,218
-14% -$1.01M 3.48% 5
2024
Q4
$6.59M Buy
8,535
+139
+2% +$115K 3.51% 7
2024
Q3
$7.44M Buy
8,396
+687
+9% +$618K 4.6% 2
2024
Q2
$6.98M Buy
7,709
+98
+1% +$78.4K 5.04% 2
2024
Q1
$5.92M Sell
7,611
-169
-2% -$120K 4.75% 3
2023
Q4
$4.54M Buy
7,780
+13
+0.2% +$7.59K 4.37% 4
2023
Q3
$4.17M Sell
7,767
-276
-3% -$142K 4.5% 3
2023
Q2
$3.77M Buy
8,043
+213
+3% +$89.3K 3.99% 5
2023
Q1
$2.69M Buy
7,830
+236
+3% +$79.6K 3.22% 5
2022
Q4
$2.78M Buy
+7,594
New +$2.69M 3.43% 3

Other funds holding LLY

Schear Investment Advisers's LLY Position: Q2 2026 in Review

Schear Investment Advisers increased its Eli Lilly (LLY) stake by 2.4% in Q2 2026, buying an estimated $171K and bringing the position to 7,178 shares worth $8.61M. The position accounts for 2.88% of the portfolio, ranked #7.

Schear Investment Advisers first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Schear Investment Advisers held 7,178 shares of Eli Lilly worth $8.61M as of Q2 2026.
  • Schear Investment Advisers bought 167 Eli Lilly shares in Q2 2026, an estimated $171K.
  • Eli Lilly made up 2.88% of Schear Investment Advisers's portfolio in Q2 2026, its #7 holding.
  • Schear Investment Advisers first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Schear Investment Advisers's 13F filing for Q2 2026, filed 27 Jul 2026.